Side Effects, Lipodystrophy: Free Telephone Conference September 15

DonateNow
Print this article

Side Effects, Lipodystrophy: Free Telephone Conference September 15

AIDS Treatment News Issue #349, August 18, 2000
John S. James


A free one-hour telephone conference with leading AIDS treatment experts will summarize highlights of the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy (September 13-15 in Toronto, Canada), where research findings about adverse reactions to antiretrovirals will be presented. The one-hour summary by phone will take place September 15, 2000, starting at 5 p.m. Pacific time / 6 p.m. Mountain / 7 p.m. Central / 8 p.m. Eastern time. Although there is no charge to participate, advance registration is required. (Alternatively, you can listen to a recording of the teleconference--no registration needed-- starting within 24 hours of the live program.)

The experts on this call will be:

* Ronald Baker, Ph.D., Editor-in-Chief, HIV and Hepatitis.com;

* Andrew Carr, M.D. (moderator), Staff Specialist, HIV Medicine and Immunology, St. Vincent's Hospital, Sydney, Australia;

* Kathleen Mulligan, Ph.D., Assistant Professor of Medicine, University of California at San Francisco, and Division of Endocrinology, San Francisco General Hospital;

* Morrie Schambelan, M.D., Professor of Medicine, University of California at San Francisco, and Chief of the Division of Endocrinology and Director of the General Clinical Research Center at San Francisco General Hospital.

To join the telephone conference, you must register in advance (first names only). To register, call 1-800-880-5121 9:00 a.m. to 5:00 p.m. Eastern time. You will be given a different phone number to call in to join the conference.

You can also email questions to the experts in advance. Send them to ronbaker@dnai.com

To hear the taped replay, which will be available within 24 hours of the telephone conference, call 1-888-207-2647; when asked for the pass code, enter 6285.

An edited transcript of the call will be available at http://www.HIVandHepatitis.com within approximately 10 days of the live program. In addition, daily reports from the Toronto conference will be posted on this site starting September 14, 2000.

This teleconference is supported by unrestricted educational grants from Agouron Pharmaceuticals and Serono Laboratories.

The Lipodystrophy Conference: For More Information

The 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy will be held September 13-15 at the Western Prince hotel in Toronto, Canada; the meeting dates are coordinated with ICAAC. Advance registration is required, and this meeting is expensive, $940. before August 21. More information is available at: http://www.intmedpress.com/lipodystrophy/start.cfm
000818
ATN34901


Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .